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Abstract
Apicomplexans are obligate intracellular parasites that invade host cells by an active process leading to the formation of a
non-fusogenic parasitophorous vacuole (PV) where the parasite replicates within the host cell. The rhomboid family of
proteases cleaves substrates within their transmembrane domains and has been implicated in the invasion process.
Although its exact function is unknown, Plasmodium ROM1 is hypothesized to play a role during invasion based on its
microneme localization and its ability to cleave essential invasion adhesins. Using the rodent malaria model, Plasmodium
yoelii, we carried out detailed quantitative analysis of pyrom1 deficient parasites during the Plasmodium lifecycle. Pyrom1(-)
parasites are attenuated during erythrocytic and hepatic stages but progress normally through the mosquito vector with
normal counts of oocyst and salivary gland sporozoites. Pyrom1 steady state mRNA levels are upregulated 20-fold in salivary
gland sporozoites compared to blood stages. We show that pyrom1(-) sporozoites are capable of gliding motility and
traversing host cells normally. Wildtype and pyrom1(-) sporozoites do not differ in the rate of entry into Hepa1–6
hepatocytes. Within the first twelve hours of hepatic development, however, only 50% pyrom1(-) parasites have developed
into exoerythrocytic forms. Immunofluorescence microscopy using the PVM marker UIS4 and transmission electron
microscopy reveal that the PV of a significant fraction of pyrom1(-) parasites are morphologically aberrant shortly after
invasion. We propose a novel function for PyROM1 as a protease that promotes proper PV modification to allow parasite
development and replication in a suitable environment within the mammalian host.
Citation: Vera IM, Beatty WL, Sinnis P, Kim K (2011) Plasmodium Protease ROM1 Is Important for Proper Formation of the Parasitophorous Vacuole. PLoS
Pathog 7(9): e1002197. doi:10.1371/journal.ppat.1002197
Editor: Kirk Deitsch, Weill Medical College of Cornell University, United States of America
Received February 9, 2010; Accepted June 22, 2011; Published September 1, 2011
Copyright:  2011 Dawson et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: IMV was supported by the Training Program in Molecular and Cellular Biology funded by National Institutes of Health (NIH) training grant NIGMS T32
GM 07491 awarded to the Albert Einstein College of Medicine. This work was supported by NIAID grants R01AI046985 (to KK), US Army Research Grant W81XWH-
05-2-0025 (to KK) and R01 AI056840 (to PS). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Kami.Kim@einstein.yu.edu
Introduction
Malaria is a pervasive infectious disease that causes one million
deaths each year and exacerbates the social and economic
instability of endemic areas [1]. Malaria is caused by Plasmodium
species, obligate intracellular protozoan parasites in the phylum
Apicomplexa. Plasmodium spp have a complex life cycle with
multiple differentiated forms that cycle between a sexual stage in
the mosquito vector and an asexual stage in the vertebrate host. As
obligate intracellular parasites, apicomplexans invade cells through
the use of highly specialized secretory organelles, the micronemes
and rhoptries [2]. Secretion from the micronemes is concurrent
with apical reorientation and attachment of the parasite to the host
cell membrane [3]. Tight apposition between the parasite and host
cell plasma membrane forms the moving junction through the
cooperation of the microneme adhesin AMA1 and the Rhoptry
Neck proteins (RON) [4–6]. As the parasite pushes itself forward
into the host cell, the moving junction, a constrictive ring that
translocates posteriorly and forms a parasitophorous vacuole (PV)
forms through the invagination of host cell plasma membrane. PV
formation is accompanied by the secretion of rhoptry contents in
the form of secretory vesicles that become incorporated into the
nascent parasitophorous vacuole membrane (PVM) [7–9]. The PV
is devoid of most host cell proteins and avoids fusion with host
lysosomes [10–11]. Proper establishment and modification of the
nascent PV is critical for the survival of the parasite.
Sporozoites and merozoites are the invasive stages of Plasmodium
parasites that form a PV as they enter their host cells, the
hepatocytes and the red blood cells (RBC), respectively. Until
recently, studies of parasite invasion and development in
hepatocytes have been limited. Much of what we know about
apicomplexan host cell invasion and PV formation comes from
studies using the model apicomplexan, Toxoplasma gondii, and from
studies using Plasmodium falciparum erythrocytic stages [2,12]. It is
likely, however, that sporozoites invade host cells in a manner
similar to T. gondii tachyzoites as illustrated in a recent study
showing the importance of host F-actin polymerization at the site
of parasite entry for T. gondii tachyzoites and Plasmodium
sporozoites [13].
Transcriptomic and proteomic analysis of Plasmodium sporozo-
ites have enabled a gene-based approach to studying this
important stage [14–17]. Sporozoites developing within the
hepatocyte undergo a radical transformation within the first few
hours post invasion. The intracellular sporozoite within its PV
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polarized shape to become spherical [18–19]. The liver stage
parasite grows and replicates within the PV ultimately releasing
membrane bound bundles of thousands of daughter merozoites
(merosomes) that then enter the erythrocytic cycle [20–21].
Pre-erythrocytic stages are considered targets for the develop-
ment of vaccines and prophylactic drugs [22–23]. Recently,
genetically modified live attenuated sporozoites that confer sterile
immunity in rodent models were generated. The deleted genes,
UIS3, UIS4, and P52 are upregulated in salivary gland sporozoites
and are crucial for development within hepatocytes. Their gene
products localize to the micronemes/secretory organelles of
salivary gland sporozoites and are necessary for early liver stage
development [24–26].
Host cell invasion by apicomplexans is associated with
proteolysis of surface proteins, which include resident surface
antigens and apically-secreted adhesion molecules, collectively
called adhesins [27–30]. Proteases implicated in shedding of
adhesins are parasite-encoded and include the subtilase class of
serine proteases and the rhomboid class of serine proteases [31].
Rhomboid proteins are polytopic membrane-associated serine
proteases that form a catalytic pocket within the lipid bilayer and
have the unique characteristic of cleaving substrates within the
transmembrane domain [32–34]. Rhomboid proteases recognize
small residues such as glycine and alanine within the transmem-
brane domains of substrates [35]. In the Apicomplexa, processing
of key microneme adhesins, such as TgMIC2, TgMIC6, TgAMA1
and PfEBA175, has been shown to occur via intramembranous
cleavage at sites predicted to be rhomboid-like substrates [36–
38,29].
The specific rhomboid protease(s) involved in these processes
have not been identified. Based on expression, localization, and
substrate specificity, two Plasmodium rhomboids, ROM1 and
ROM4, are predicted to play a role during invasion. PfROM1
is co-localizes with microneme markers has the ability to cleave
certain microneme invasion adhesins such as PfAMA1,
PfMAEBL, certain EBLs, and rhoptry proteins of the Rh family
in a cell based assay [29,39]. In addition, a separate study reported
that PfROM1 is localized to a new apical organelle, the
mononeme [40]. When expression of the PfROM1 ortholog in
Toxoplasma gondii, TgROM1, is down regulated in tachyzoite
parasites, there is a slight growth phenotype and mild invasion
defect compared to the wildtype control [41]. Disruption of pbrom1
in Plasmodium berghei led to attenuation ascribed to an invasion
defect [42], however, invasion of parasites into host cells was not
directly tested in this study.
It is still unclear if ROM1 plays a role during Plasmodium
parasite invasion. Using the rodent malaria parasite, Plasmodium
yoelii, we investigated the specific role of ROM1 during the
parasite lifecycle. We show that ROM1 is not required for entry
into host cells but, instead, ROM1 is necessary shortly after the
parasite has entered the host cell to promote fitness and parasite
survival.
Results
PyROM1 is expressed in all invasive stages of the parasite
lifecycle, with increased expression during sporozoite
stages
Pyrom1 was cloned from cDNA of Plasmodium yoelii 17XNL
mixed blood stages using 59 and 39 Rapid Amplification of cDNA
Ends (Smart RACE Clontech). The sequence obtained consists of
4 exons and 3 introns, encompassing two annotated genes on
PlasmoDB, py00729 and py00728. Based on topology predictions
(TMHMM and HMMTOP), PyROM1 has seven transmembrane
domains with the canonical rhomboid catalytic serine motif
(GASTS) found within transmembrane domain four and a
conserved histidine found within transmembrane domain six
(merops.sanger.ac.uk). It has an N-terminal tail of 52 amino acids
that includes the conserved microneme targeting motif YPHY [43]
and a very short carboxy terminal tail (Figure S1).
Based on the P. falciparum DNA microarray data, expression of
pfrom1 is similar to genes involved during invasion with a
significant upregulation in the sporozoite stage [44–45]. We
quantified pyrom1 mRNA in several stages of the malaria life cycle
using quantitative RT-PCR (Figure 1A). Amplification of Pyrom1
cDNA from synchronized erythrocytic stages shows modest
expression, with greatest expression in schizont (S) stages. There
is a 10-fold increased expression in midgut (MG) sporozoites and a
20-fold increased expression in salivary gland (SG) sporozoites
relative to expression levels of schizont stages. To control for
appropriate expression analysis, additional expression profiles of
other known genes (PyAMA1, PyUIS3, PyADA, PyTUB1, and
PyCSP) was carried out using the same cDNA (Figure S2).
To further characterize pyROM1 expression at the protein
level, we generated a transgenic line that expresses pyROM1
tagged at the N-terminus with a triple hemaglutinin tag (3xHA).
Single cross-over homologous recombination using hDHFR
selection cassette yields the expression of the HA-tagged pyrom1
open reading frame driven by its own 59 and 39 regulatory
elements (Figure 1B). Successful integration of the knock-in
construct was verified by Southern blot analysis of genomic
DNA from mixed erythrocytic stage transgenic parasites R1HA
(Figure 1C). Western blot analysis of erythrocytic and sporozoite
stages of PyROM1-HA reveals a band that migrates at the
expected size of ,30 kDa on SDS-PAGE (Figure 1D and 1E). In
synchronized erythrocytic stages, PyROM1-HA protein expres-
sion is lowest in ring stages (3 hours post invasion) and increases
during the course of development with a peak in schizont stages
(Figure 1D). In sporozoite stages, PyROM1-HA is readily
expressed in salivary gland sporozoites with very minimal
expression in midgut sporozoites. The expression pattern of
PyROM1 at the mRNA and protein level implies a function at
Author Summary
Plasmodium parasites are obligate intracellular organisms
that invade cells by an active mechanism mediated by the
secretion of contents from specialized secretory organ-
elles, the micronemes and rhoptries. Invaded parasites
reside and replicate within a membrane-bound compart-
ment called the parasitophorous vacuole (PV). PV forma-
tion is exclusive to development within mammalian
specific host cells, the erythrocytes and hepatocytes.
Proper modification of the PV is important to protect the
parasite from host defenses and to serve as a gateway for
nutrient acquisition and communication with the environ-
ment. The rhomboid proteins, a class of intramembrane
serine proteases, are implicated in the invasion process.
We studied the microneme rhomboid protease, ROM1 in
the rodent malaria parasite, Plasmodium yoelii. We find
that pyROM1 is not important for efficient invasion into
host cells and instead is important for survival within the
host cells. Analysis of parasites developing within hepato-
cytes reveals a defect in PV development. We propose that
pyROM1 provides a fitness advantage to parasites
developing within host cells by promoting the proper
modification of the PV.
Plasmodium Protease ROM1 and Vacuolar Development
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importance for the zoite stages that mediate host cell invasion.
pyROM1 co-localization with secretory markers
PyROM1-HA co-localizes with the microneme adhesin,
pyMAEBL and with the rhoptry neck protein RON4 at the
apical end of merozoites within mature schizonts by immunoflu-
orescence (Figure 2A). Although localization overlapped more
consistently with pyMAEBL than RON4, pyROM1 shows partial
co-localization with both markers. Some localization overlap is
observed between PyROM1-HA and the endoplasmic reticulum
(ER) marker BiP (Figure 2A). PyROM1-HA is found in a speckled
intracellular pattern in salivary gland sporozoites (day 14) that
partially overlaps with localization of PyMAEBL and PyUIS4
(Figure 2B). Some co-localization is observed with BiP in salivary
gland sporozoites (Figure 2B). During sporozoite invasion into
Figure 1. Stage-specific expression of pyROM1 during the malaria life cycle. (A) Real time PCR using cDNA prepared from synchronized
blood stage parasites, mosquito derived parasites, and hepatic stage parasites of P. yoelii 17XNL. Expression levels were normalized to 18s rRNA and
calculated relative to the Schizont (S) transcripts, set as 1. Parasite stages are abbreviated as follows: MG, Midgut sporozoites (Day 10); SG, Salivary
Gland sporozoites (Day 14); 6, sporozoite development at 6 hours post-invasion; 24, Liver trophozoite development at 24 hours; 42, Liver schizont
development at 42 hours; R, Blood stage rings; T, blood stage trophozoite; S, blood stage schizont. (B) Schematic of knock-in strategy using pR1HA
construct consisting of the pyrom1 ORF fused to an N-terminal triple HA tag under the control of its 59 and 39 regulatory elements. (C) Restriction
digest strategy described in (B) was used to test integration of the knock-in construct. Homologous recombination of knock-in construct pR1HA into
the pyrom1 locus creates an MscI (M) restriction site that is specific to the hDHFR coding sequence. Restriction sites BstZ171 (B) lie just outside the
pyrom1 sequence used in pR1HA knock in vector. Digestion of PyROM1-HA (R1HA) gDNA yields a two fragment restriction pattern (B,M – 5.758 bp;
M,B – 9.190 bp) when a probe specific to the 39 flanking region is used (dumbbell bar). Digestion of wildtype (Wt) gDNA with both enzymes yields a
single fragment (B,B – 7241 bp) using the same probe. (D) Western blot analysis of synchronized blood stage parasites using lysates from pyROM1-
HA recombinant clone probed with anti-HA antibody reveals a band of the expected size, ,30 kDa (R: Ring, T: Trophozoite, T/S: late Trophozoite/
Schizont, S: Schizont). Mixed blood stages of wildtype parasites were loaded as a negative control (Wt). Saponin-released parasite lysates were loaded
at 40 ug per lane to normalize for protein amounts. Coomassie Blue stained gel is shown below Western blot to serve as a loading control (E) Western
blot analysis of midgut (MG) and salivary gland (SG) sporozoites from pyROM1-HA knock in parasites probed with anti-HA antibody (100,000
sporozoites/lane). Shown below is the same Western blot probed with anti-PyCSP (2F6) antibody to serve as loading control.
doi:10.1371/journal.ppat.1002197.g001
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PLoS Pathogens | www.plospathogens.org 3 September 2011 | Volume 7 | Issue 9 | e1002197Figure 2. PyROM1 localizes with microneme markers and is not present at the parasite surface during sporozoite invasion. (A)
Immunofluorescence assay of blood stages shows partial co-localization of PyROM1-HA (R1HA) with the microneme protein pyMAEBL and the
rhoptry neck marker RON4 in schizont merozoites. PyROM1-HA also partially overlaps the ER marker BiP in schizonts. (B) Immunofluorescence assay of
pyROM1-HA (R1HA) salivary gland sporozoites reveals that pyROM1 partially co-localizes with the microneme marker PyMAEBL and with the eTRAMP
protein PyUIS4 within diffuse intracellular granules throughout the length of the parasite body. Restricted localization that excludes the area
Plasmodium Protease ROM1 and Vacuolar Development
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pattern diffusely dispersed throughout the sporozoite (Figure 2C).
Expression of pyROM1-HA is observed in developing EEFs at
four hours post invasion with intracellular localization throughout
the length of the parasite that is distinct from the localization of the
sporozoite surface antigen, circumsporozoite protein (CSP)
(Figure 2C).
Genetic targeting of the gene encoding ROM1 in P. yoelii
To investigate the importance of pyrom1 in the parasite life cycle,
we employed a reverse genetics approach to generate loss-of-
function deletion mutants. Initially we used a single crossover
homologous recombination step to disrupt the endogenous pyrom1
locus. Successful disruption of the pyrom1 gene was confirmed by
Southern blot and RT-PCR (Figure S3). Disrupted parasites
(R1INT) were used to carry out initial phenotypic screens. Because
single crossover disruptants can revert to wildtype [46–47] we also
created a deletion mutant that would allow us to cycle the parasites
between the mammalian host and mosquito vector without the risk
of reversion. We used a gene replacement vector to exchange the
endogenous pyrom1 gene for a pbDHFR/TS-GFP cassette by
double crossover homologous recombination [48]. The targeting
vector contains the pbDHFR-TS/GFP selection cassette, which
confers pyrimethamine resistance, flanked by DNA fragments
from the upstream (59ARM) and downstream (39ARM) regions of
the predicted open reading frame of pyrom1. We successfully
integrated the replacement cassette, deleting exons 1–3 of the
pyrom1 gene that include the region encoding the functional
catalytic serine motif and the conserved histidine (Figure 3A).
Recombinant parasites were detected by diagnostic PCR of
genomic DNA from wildtype and transfected parasites. Cloning of
pyrimethamine-resistant parasites yielded two knock out clones
(R1KO-1 and R1KO-2) and a wildtype clone (Wt Ctrl). Southern
blot analysis of genomic DNA from mixed blood stages confirmed
successful cloning of pyrom1 deletion mutants (R1KO) (Figure 3B).
RT-PCR analysis of mutant clones revealed no detectable pyrom1
transcript expression, whereas pyrom1 expression was detected in
the wildtype control clone (Figure 3C). The successful generation
of P. yoelii 17XNL parasites deficient in pyrom1 demonstrates that
this gene is not essential for proliferation of the intra-erythrocytic
stages.
Pyrom1(-) parasites are attenuated in the mammalian
host
To test whether PyROM1 serves an important function during
asexual growth within red blood cells, we performed in vivo
infectivity assays. Six-week old female BALB/c mice (n=5) were
injected intravenously with 1610
4 infected red blood cells (iRBCs)
and parasitemia was monitored every 24 hours by counting
Giemsa-stained blood smears. Since the pyrom1(-) parasites were
generated in P. yoellii 17XNL, a non-lethal strain, the parasitemia
in mice reached a peak and parasites were then cleared by the
mouse immune system. We monitored parasitemia until infected
erythrocytes were undetectable. Growth curves revealed a mild
attenuation of pyrom1(-) (R1KO) with a decrease in peak
parasitemia (25% versus 43%) and a decrease in the duration of
infection compared to the wildtype control (Wt Ctrl) (Figure 4A).
Infection of BALB/c mice (n=5) with salivary gland sporozoites
by natural mosquito bite or by intravenous injection (inoculum of
20–2000) revealed that mutant parasites could establish a liver
infection leading to blood stage infection with a pre-patent period
of three days (Table S1). Therefore, pyrom1(-) parasites are able to
progress through the entire lifecycle. Due to the highly infectious
nature of P. yoelii sporozoites in vivo, it is difficult to quantify liver
development by relying solely on pre-patency period [49].
Therefore, we analyzed the development of pyrom1(-) sporozoites
in vivo using quantitative RT-PCR, a more sensitive assay to
quantify hepatic development [50]. BALB/c mice were injected
intravenously with equal numbers (1610
4) of salivary gland
sporozoites from wildtype control or pyrom1(-) parasites. Livers
were harvested at 36 hours and RT-qPCR analysis was carried
out. Parasite burden in mice infected with pyrom1(-) parasites was
decreased by at least 60% compared to mice infected with
wildtype parasites (Figure 4B). Similar results were seen with livers
harvested at 24 hours and 42 hours from mice infected with 10
4
salivary gland sporozoites (data not shown). This difference in liver
burden suggests that pyROM1 is important for efficient sporozoite
infection in the liver.
Pyrom1 is not essential for transmission through the
mosquito vector
Since pyrom1 is robustly expressed in sporozoite stages, we
investigated the effect of pyROM1 depletion in the mosquito
phase of the parasite life cycle. Analysis of blood smears showed no
difference in the capacity to produce gametocytes between
wildtype and R1KO parasites (Table 1). No significant difference
was seen in the number of oocysts (day 8 post infection) per
mosquito midgut or in the prevalence of infected mosquitoes
between wildtype and R1KO parasites (Table 1). Furthermore,
there was no difference in the number of salivary gland associated
sporozoites (day 14 post infection) in R1KO mutant parasites
compared to wildtype in three independent experiments, testing
two R1KO clones (Table 1). Thus, deletion of pyrom1 does not
affect development of oocysts, sporozoite release into the
hemolymph, or invasion of salivary glands.
Pyrom1(-) salivary gland sporozoites glide and invade
host cells normally
A decrease in liver stage infection in vivo can be attributed to a
defect in sporozoite motility or cell traversal ability [51–55].
Potential rhomboid substrates such as the microneme adhesin,
TRAP, bridge the function of gliding motility and host cell
invasion [56–57]. To begin an in-depth analysis of the function of
pyrom1 in salivary gland sporozoites, we tested gliding motility and
cell traversal of pyrom1(-) parasites. Gliding trails formed by the
deposition of circumsporozoite protein (CSP) on glass slides by
sporozoites were readily detectable in the pyrom1 disrupted
(R1INT) parasites (Figure 5A) and the quantity and quality of
trails produced by wildtype and R1INT sporozoites were similar
(Figure 5B).
A unique feature of salivary gland sporozoites is their ability to
use the motility machinery to traverse cells without productively
invading a host cell and forming a PV [58]. When sporozoites
traverse cells they glide in and out of the cell puncturing the
plasma membrane and causing host cell injury. Host cell traversal
can be detected by quantifying host cells that take up non-
permeable high molecular weight FITC-dextran, in the presence
surrounding the nucleus is observed between PyROM1-HA and the ER marker BiP. (C) Localization of pyROM1-HA during invasion into Hepa 1–6 cells.
The extracellular portion of parasite stains with CSP. Intracellular localization of pyROM1-HA in a developing EEF at 4 hours post invasion into Hepa
1–6 cells has overlap with CSP.
doi:10.1371/journal.ppat.1002197.g002
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difference in cell traversal activity between wildtype or R1KO
sporozoites (Figure 5C).
To test the importance of pyROM1 during host cell invasion,
we performed a double labeling invasion assay that distinguishes
parasites that are intracellular versus parasites that are extracel-
lular [60–61]. The number of intracellular sporozoites between
wildtype and pyrom1(-) parasites did not differ at two hours post
invasion (Figure 5D). Invasion rates at 10, 20, and 40 minutes
after loading onto Hepa1–6 monolayers did not differ significantly
between Wt Ctrl and R1KO, illustrating no significant difference
in the kinetics of invasion between wildtype and R1KO
sporozoites into Hepa1–6 cells (Figure 5E). Together, these results
indicate that pyROM1 is not important for efficient host cell entry
or for establishment of a successful infection during the early stages
of sporozoites in host cells.
Pyrom1(-) parasite development in hepatocytes
decreases in the first 24 hours
Analysis and quantification of sporozoite development in Hepa
1–6 cells at 6, 12, and 24 hours post invasion was carried out using
fluorescence microscopy. Differential red-green staining of pyCSP
was carried out to distinguish intracellular versus extracellular
parasites at 6 hours post invasion. By 6 hours, exoerythrocytic
forms (EEF) have begun to round up and change morphology as a
prelude to development in hepatocytes. The percent of R1KO
developing sporozoites in Hepa 1–6 cells was decreased at 6 hours
compared to wildtype sporozoites (Figure 6A) but this difference
Figure 3. Generation of pyrom1(-) parasites by allelic exchange. (A) Schematic of targeting strategy using the targeting vector pR1KO which
has the pbDHFR/TS-GFP selection cassette flanked by a 59homologous arm (600 bp) and a 39 homologous arm (600 bp) corresponding to the 59 and
39 regions of the pyrom1 gene, respectively. After double cross over homologous recombination the endogenous pyrom1 gene is replaced by the
selection cassette resulting in parasites deficient for pyrom1 (R1KO). (B) Proper gene replacement was verified by Southern Blot analysis in two
knockout clones (KO1, KO2). Strategy for enzyme restriction digestion with either ScaI (S) or a combination of ScaI and MscI (M) using a probe
(dumbbell bar) specific for the 39 homologous arm is depicted in (A). A ScaI fragment that corresponds to the wildtype (Wt) genomic locus migrates
at ,7000 bp in both blots. Digestion of the recombinant locus (R1KO) with either ScaI/MscI or ScaI reveals expected bands migrating at the expected
sizes of ,4000 bp and ,12,000 bp, respectively. (C) Lack of pyrom1 gene expression in R1KO clones from mixed blood stages was verified by RT-PCR.
Analysis of pyADA expression, an unrelated gene, was used as a positive control. Expression of pyrom1 was analyzed using primers, R1-F and R1-R,
which amplify the Open Reading Frame (ORF) of pyrom1. The expected pyrom1 ORF band (expected size ,800 bp) is readily amplified from wildtype
(WT) cDNA, but is not amplified from cDNA of the two pyrom1(-) clones (KO-1 and KO-2).
doi:10.1371/journal.ppat.1002197.g003
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number of developing foci of R1KO exoerythrocytic forms (EEFs)
had significantly decreased by 45% compared to the number of
wildtype EEF foci (P-value 0.008; Figure 6B). By 24 hours post
infection, R1KO EEF development was decreased by more than
60% compared to wildtype EEF development (P-value 0.001;
Figure 6C). This time course analysis of EEF development suggests
that pyROM1 enhances the survival of developing sporozoites
within hepatocytes during the critical stages of early intra-
hepatocytic development.
Although the number of developing EEFs decreased with each
time point, the R1KO EEFs that were observed still exhibited
morphological characteristics of parasites that had progressed
appropriately during development. For example, these EEFs
exhibited rounding up of the elongate sporozoite, increase in cell
size, and juxta-nuclear position within host cell (Figure 6D). To
determine the fate of the fraction of parasites that survive past the
initial 24 hours post infection, we allowed parasites to develop in
Hepa1–6 for 40 hours. By this time, the EEF has grown in size
and has undergone several rounds of multiplication, becoming a
liver schizont (i.e. mature EEF). Liver schizonts were analyzed
microscopically by staining with CSP to determine if pyROM1
plays a role during growth and later development stages of EEF
maturation. Quantification of EEF area reveals that R1KO
parasites that survived the initial stages of development are able to
proceed with normal growth and cell division (Figure 6E).
The parasitophorous vacuole protein, UIS4, is a rhomboid
substrate and its association with the PV is decreased in
Pyrom1(-) parasites
Proper establishment and modification of the PV in newly
invaded parasites is a prerequisite for intracellular survival and
growth. The early transcribed membrane proteins (eTRAMPs) are
highly charged type I integral membrane proteins that localize to
secretory organelles and associate with the PVM shortly after
parasite invasion [15,62]. The eTRAMP UIS4 (Upregulated in
Sporozoites 4) is specifically upregulated in salivary gland
sporozoites and is essential for parasite development in host
hepatocytes [24]. In salivary gland sporozoites, UIS4 co-localizes
with TRAP to secretory organelles [15] and is secreted at some
point post invasion (within 2 hours) to become incorporated into
the PVM [24,63]. To assess whether the defect in pyrom1(-)
parasite development in host hepatocytes was due to a defect in
PV formation, we tested for the presence of PyUIS4. Sporozoites
within hepatocytes were labeled with CSP mAb and UIS4 antisera
at 2 hours and 6 hours post infection and quantified microscop-
ically. The total number of parasites (intracellular and extracel-
lular) was determined by CSP staining. The percent of developing
parasites surrounded by a UIS4-positive PVM was calculated as
the number of parasites that showed double staining with UIS4
and CSP. R1KO parasites had a 33% and 43% decrease
compared to wildtype parasites of UIS4 positive staining at
2 hours and 6 hours, respectively (P-value 0.010) (Figure 7A).
Pyrom1(-) parasites negative for the circumferential staining typical
of UIS4 localization to the PVM, often times had a punctuate
localization of UIS4 within the sporozoite body (Figure 7B).
The eTRAMP proteins possess a conserved TMD with
sequence similarity to known rhomboid substrates [32]. To test
if the TMD of UIS4 is a potential rhomboid substrate we carried
out a previously established heterologous cleavage assay where
rhomboid and substrate are transiently co-expressed in COS7 cells
and analyzed via Western blot [39]. A truncated version of
PyUIS4 encompassing the full TMD with an N-terminal GFP tag
and an IgK leader sequence (UIS4TMGFP, Figure 7C,Table S3)
was co-expressed with HA-tagged rhomboid protease. Proper
expression of rhomboid proteases was observed in Western blots
probed with anti-HA antibody (Figure 7D). A single band running
at ,40 kDa corresponding to full length UIS4TMGFP was
observed in Western blots of cell lysates probed with anti-GFP
antibody (Figure 7D). A lower molecular weight band (,34 kDa)
corresponding to the expected size of a rhomboid cleaved product
was observed in cell lysates and conditioned media only when
UIS4TMGFP was co-expressed with the D. melanogaster rhomboid
protease, DmRho-1 (Figure 7D). No cleavage activity was readily
observed when UIS4TMGFP was co-expressed with either
TgROM5 or its catalytic mutant (TgROM5
SA) (Figure 7D).
Therefore, it can be concluded that PyROM4, and potentially
other eTRAMPs, can serve as substrates to rhomboid proteases.
Figure 4. Phenotypic analysis of pyrom1(-) mutant parasite in
the mammalian host. (A) Female Balb/c mice, 6 weeks of age (N=5)
were infected with mixed blood stage parasites from either P. yoelii
17XNL wildtype control (Wt Ctrl) or pyrom1(-) clones R1KO -1 and R1KO-
2 by tail intravenous injection with 1610
4 iRBC. Percent parasitemia
(infected Red Blood Cells/Total Red Blood Cells 6 Std) was calculated
on a daily basis from Giemsa stained smears counting at least 1000 total
Red Blood Cells per smear. Values presented are the mean parasitemia/
day from each infected group with the error as the standard deviation.
Parasitemia was measured until the mice had cleared the infection. (B)
Salivary gland sporozoites (SPZ), 10
4, were injected intravenously into 6
week Balb/c female mice (N=5). At 36 hours post infection, whole livers
were taken RNA was extracted for quantitative RT-PCR analysis. Liver
burdens were determined as the levels of Plasmodium 18S rRNA
transcript expression normalized to mouse GAPDH expression levels.
Liver burden, defined as the level of parasites in liver based on 18S
expression levels, was decreased in the two pyrom1(-) parasite (R1KO-1
and R1KO-2) infected mice relative to mice infected with wildtype (Wt
Ctrl) parasites. Fold change was calculated using the ddCt (2
2ddCt)
method and relative transcript levels are shown.
doi:10.1371/journal.ppat.1002197.g004
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inability to properly secrete UIS4 into the PVM. Furthermore, a
rhomboid protease may be involved in the proper maturation,
processing and targeting of PyUIS4 to the PVM since the TMD of
UIS4 serves as a rhomboid substrate.
Electron microscopic analysis of Pyrom1(-) parasites
reveals a difference in PV formation
To investigate whether pyrom1(-) parasites have a defect in PVM
formation, we carried out ultrastructural analysis of R1KO
parasites during early intra-hepatocytic development. Intracellular
parasites at 4 hours post infection of Hepa1–6 cells were analyzed
by electron microscopy. R1KO parasites (19 of 42) exhibited a
strikingly reduced intravacuolar space with the PVM in close
apposition to the plasma membrane of the parasite. In wildtype
vacuoles this parasitophorous vacuole space has expanded and
appears as a white ‘‘halo’’ surrounding the developing parasite
inside a PVM and only one of 38 vacuoles had a closely apposed
PVM Figure 8A, Figure S4, Table S2). To quantify this phenotype
we measured the area of the PV space (halo) as the difference
between the area of the total PV space and the parasite area. This
value was then normalized to the area of the parasite to give a
ratio that represents the percentage of the PV space area relative
to the parasite and is a representation of the extent of PV space
expansion. Wildtype parasites had a significantly (P-value 0.0007)
larger ratio value (0.1760.02) compared to R1KO parasites
(0.0960.01) (Figure 8B). To quantitatively show the existence of
two populations, we plotted the distribution of parasites as a
function of PV space area/parasite area ratio. The distribution
plot clearly shows the existence of two parasite populations within
the R1KO group (Figure 8C). We hypothesize that the R1KO
parasites with a normal PV space go on to develop past the initial
24 hours of development and the R1KO parasites with a reduced
PV space abort development within the initial 24 hours. A few
parasites in direct contact with the cytoplasm or nucleoplasm were
observed in both wildtype (4/38) and R1KO (2/42) parasites,
which we assume be sporozoites in traversal mode [64]. This
ultrastructural analysis indicates that while R1KO parasites are
capable of productively invading host cells with the formation of a
PVM, a fraction of them have a defect in the subsequent PV
expansion and modification in early development.
Discussion
Successful transmission of malaria into the mammalian host is
dependent on the ability of sporozoites to invade and establish a
proper PV within the host hepatocyte. To date, only a handful of
genes have been identified that play a role during invasion or early
development of the sporozoite within hepatocytes. In this study we
have characterized the rhomboid protease, ROM1, throughout
the lifecycle of the malaria rodent model, Plasmodium yoelii.
Quantitative expression analysis of pyrom1 shows it is expressed
at various invasive stages of the malaria life cycle. Expression of
pyrom1 follows a pattern similar to genes involved in merozoite
invasion with maximal erythrocytic stage expression in schizonts.
Relative to schizont stages, expression of pyrom1 is increased by at
least 10-fold during the sporozoite stages with pyrom1 transcript
levels upregulated by 2-fold from midgut sporozoites to salivary
gland sporozoites. Midgut sporozoites are substantially less
infectious in the mammalian host compared to salivary gland
sporozoites [14,65]. This gain of infectivity has been ascribed in
part to transcriptional changes that occur when sporozoites invade
mosquito salivary glands [14–15]. In addition, we observe that,
although transcript expression of pyrom1 is elevated in midgut
sporozoites, protein expression is barely detectable by Western
blot, suggesting regulation of pyrom1 gene expression at the level of
transcript translation in midgut sporozoites. The upregulated
expression of ROM1 mRNA and protein in salivary gland
sporozoites is consistent with a role during infectivity and
transmission into the vertebrate host. Supporting our observations,
a microarray study looking at gene expression changes triggered
by different host environments (i.e. mosquito host to mammalian
host) reported that pfrom1 is upregulated 4-fold when salivary gland
sporozoites are shifted to 37uC in the presence of hepatocytes [66].
We have localized PyROM1 at various stages during the
malaria life cycle. In schizonts, PyROM1-HA is localized to the
apical end. In salivary gland sporozoites PyROM1-HA has a
diffuse granular staining pattern similar to microneme proteins
such as PyMAEBL. Microneme localization of PyROM1 agrees
with previous studies of ROM1 localization in both Toxoplasma
gondii and Plasmodium spp [67–68,41–43,29], but in our study this
localization was only partial. Localization of pyROM1-HA in
sporozoites during invasion revealed that it remains intracellular
Table 1. PyRom1(-) parasites progress normally through the mosquito vector.
Exp. Mouse Line % Gct
a Mean Oocyst/msq
b N
c Prevalence
d p-value vs. Ctrl
e Sporozoites/Msq
f
1 WT Ctrl 0.5460.22 69618.10 18 83% - 23,47063965
R1KO-1 0.3760.14 107.6622.00 14 93% P.0.05 21,43761738
R1KO-2 0.4660.00 51.63611.32 19 84% P.0.05 21,7726561
2 WT Ctrl 0.6260.19 34.5611.19 18 100% - 28,75963960
R1KO-1 0.7460.45 35.17610.33 18 94% P.0.05 24,7806184
R1KO-2 0.4460.12 40.94610.33 17 88% P.0.05 23,2556648
3 WT Ctrl 0.6260.22 70.5613.14 24 100% - 20765.56477
R1KO-1 0.3560.10 64.44616.81 16 93% P.0.05 195346854
R1KO-2 0.3660.15 43.7369.647 22 91% P.0.05 1894761654
a)Percent gametocytemia calculated per mouse used during mosquito feeding. Shown is the mean with standard deviation.
b)Mosquito midguts dissected at day 8 post feeding. Mean number oocysts per midgut reported with Standard Error Mean.
c)Number of midguts dissected and counted per parasite line for each experiment.
d)Prevalence is calculated as the percentage of infected midguts over total midguts analyzed.
e)Statistical analysis using non parametric 2-way ANOVA/Tukey’s post test with Prism Graph Pad.
f)Salivary glands dissected at day 14 post feeding. Mean number of sporozoites/mosquito is reported 6 standard deviation.
doi:10.1371/journal.ppat.1002197.t001
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invasion. There is no consensus on the localization of ROM1
during apicomplexan invasion since some studies report surface
expression and posterior translocation [40,43] and others report
internal localization during invasion [29,41]. Because of differ-
ences in the experimental conditions and expression constructs
used for these localization studies, results are difficult to compare.
Using a gene deletion approach, we demonstrate that pyROM1
functions during intracellular growth, within hepatocytes and
erythrocytes, to provide a fitness advantage. Quantitative analysis
of parasite development within Hepa1–6 cells revealed that
PyROM1 is not essential for sporozoite invasion into the host
cells. Instead, survival of pyrom1(-) parasites decreases within the
first 24 hours post invasion. It is during these first 24 hours of
development that Plasmodium sporozoites undergo critical mor-
phological changes such as PV modification, sphericalization of
the elongate sporozoite, and increase in cytoplasmic size [18–
19,69]. PyROM1 may facilitate these initial vital steps during liver
stages by allowing parasites to reach the critical threshold required
to survive past the first 24 hours of differentiation. This in vitro
development phenotype was confirmed in vivo when mice infected
with pyrom1(-) sporozoites had decreased parasite liver burden at
36 hours post infection.
Our results agree with previous studies showing that lack of
ROM1 expression causes a decrease in parasite survival [41–42].
In a previous study, disruption of pbrom1 resulted in attenuation
during erythrocytic stages, a decrease in oocyst formation, and a
decrease in liver stage burden [42]. One major difference between
Figure 5. Pyrom1(-) salivary gland sporozoites have no defect in gliding, traversal, or host cell invasion. (A) Salivary gland sporozoites
from wildtype or the pyrom1 disrupted parasite line (R1INT) were allowed to glide on glass and gliding trails of deposited CSP were stained were
visualized under fluorescent microscope (B) Quantification of sporozoite trails was carried out in triplicate and at least 25 fields were counted per well.
The number of circular trails were quantified per sporozoite and shown is the mean percentage (6 SD) of sporozoites that were associated with 0, 1–
2, 2–10, or .10 circular trails. (C) Salivary gland sporozoites were loaded on top of a monolayer of Hepa 1–6 cells in the presence of 1 mg/ml FITC-
dextran and allowed to traverse cells. As an internal negative control, sporozoites were treated with the microfilament inhibitor Cytochalasin D (CytD)
prior to loading on top of Hepa 1–6 cells. The numbers of FITC-positive cells/field were counted under the microscope. The mean number of
fluorescent cells/field (6 SD) is shown for a representative. (D) Salivary gland sporozoites were loaded on Hepa1–6 monolayers and allowed to invade
for two hours. A double staining assay was carried out to distinguish intracellular versus extracellular parasites. The % invasion was calculated as the
number of (Green - Red parasites)/(Green parasites). Values presented are the mean number counts relative to the wildtype control (set to 1) 6
standard deviation. (E) Kinetics of invasion was analyzed at three time points (10 min, 20 min, 40 min) during early invasion using the double staining
assay described in (D). Y-axis values represent the % invasion of partially invaded or fully invaded parasites 6 standard deviation.
doi:10.1371/journal.ppat.1002197.g005
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detect a decrease in the number of oocyst during development in
the mosquito midgut. This difference in phenotypic observation
can be attributed to the different methodologies used to analyze
this stage. Oocyst development is biologically variable due to
multiple factors such as host immunology (mosquito and
mammalian), parasite variability, biological bottle necks, and
other environmental conditions. Therefore, it is imperative that
careful and repeated quantification and analysis of oocyst
development be carried out in order to obtain statistically
reproducible results. We have analyzed oocyst development in
pyrom1(-) parasites thoroughly through multiple repeated experi-
ments (at least three independent experiments) performed
simultaneously with wildtype controls, using different batches of
mosquitoes, and multiple parasite clones.
We have analyzed the development of pyrom1(-) parasites in
hepatocytes thoroughly by using well-established in vitro develop-
ment and invasion assays. Thus our studies have extended our
understanding of ROM1 function and have pinpointed more
precisely the role of ROM1 during intracellular development.
Brossier et al, studied ROM1 in Toxoplasma gondii tachyzoites and
found that TgROM1 knockdown parasites had a 50% reduction
in the number of daughter tachyzoites per vacuole [41]. Based on
measurement of EEF area, we did not detect a defect in pyrom1(-)
parasite growth per vacuole, but an overall decrease in the number
of developing parasites. Therefore, we predict that the intracellular
parasites abort development in the stages preceding multiplication.
This difference in phenotype between the TgROM1 knockdown
parasites and our pyrom1(-) parasites may be explained by
fundamental biological differences in the mode of replication
between the two genera. Toxoplasma gondii tachyzoites divide by
endodyogeny, a process where two daughter cells are formed
within a mother cell, whereas Plasmodium parasites divide by
schizogony a process where nuclear division leads to the formation
of a multinuclear syncytium followed by the budding off of
daughter merozoites at the periphery [70]. Thus, the events that
Figure 6. Development of pyrom1(-) EEF is significantly reduced within the first 24 hours of hepatic development. Development of
sporozoites within Hepa 1–6 cells was analyzed at 6 hours, 12 hours, and 24 hours post invasion. (A) A double staining assay was carried out to
determine the number of intracellular parasites undergoing development inside Hepa1–6 cells at 6 hours post infection The % intracellular parasites
was determined by counting at least 30 fields per well. Values shown are the mean % intracellular parasites from duplicate counts 6 standard
deviation. The values were not statistically significant (P-value 0.17) using unpaired t test analysis. Parasite development at 12 hours (B) and 24 hours
(C) post infection was assayed by staining with a-pyCSP and developing parasites per field were counted (at least 30 fields were counted per well).
The numbers represented are the mean values of developing parasites/15 fields 6 standard deviation. At 12 hours development there is a 45%
reduction in pyrom1(-) parasite development (P-value 0.008 using one-way ANOVA analysis) and at 24 hours there is at least a 60% reduction in
pyrom1(-) parasite development (P-value 0.001 using one-way ANOVA analysis) D) Images of developing liver stage parasites at 6 hours and 12 hours
stained with CSP show that despite reduced numbers, R1KO parasites are capable of undergoing the initial differentiation, transformation, and
sphericalization during early hepatic development. (E) Development of pyrom1(-) parasites that survive the initial 24 hours go on to develop normally.
Immunofluorescence of exo-erythrocytic forms (EEF) at 40 hours post invasion of Hepa1–6 cells was performed using anti-pyCSP to visualize
developing parasites. Pictures of at least 50 EEF/well (duplicate) were taken. Area of EEF was measured using Image J software. Area was determined
as an arbitrary value from images taken with the same magnification (406). Bar graphs represent the mean area 6 SEM.
doi:10.1371/journal.ppat.1002197.g006
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survival and development of the respective parasites [71].
The malaria parasite has four invasive stages: the ookinete, the
midgut sporozoite, the salivary gland sporozoite, and the
erythrocytic stage merozoite. Only two of these invasive zoites,
the merozoite and the salivary gland sporozoite, form a PV, within
which, growth and division of the parasite ensues. The phenotype
displayed by pyrom1(-) parasites is only observed during the two
stages where PV formation is a prerequisite for growth. The PVM
provides a barrier that protects the parasite from host cell defenses
such as lysosomal clearance or autophagy [72–73]. This barrier is
also the portal for nutrient acquisition and communication with
the external environment. The intravacuolar parasite must modify
and rearrange the PV through the secretion of contents from
rhoptries and dense granules, with molecules that are yet to be
fully characterized. The exclusivity of the pyrom1(-) phenotype
Figure 7. The parasitophorous vacuole protein PyUIS4 is a rhomboid substrate and its association with the PVM is decreased in a
fraction of Pyrom1(-) parasites. (A) Immunofluorescence assay was performed on methanol fixed and permeabilized parasites post hepatocyte
invasion at 2 hrs and 6 hrs development. The parasitophorous vacuole membrane (PVM) was detected by staining with a-pyUIS4. Parasites (both
extracellular and intracellular) were stained with pyCSP. The percent UIS4-CSP double stained parasites was determined by counting parasites
staining with both UIS4 (PVM staining; see B) and CSP and dividing this number by the number of parasites staining with CSP (total parasites
including extracellular parasites). Numbers are the average of triplicates 6 SEM (at least 300 parasites counted) and were statistically significant using
the unpaired t test analysis. (B) Images from experiment in (A) of sporozoites at 2 hours post Hepa1–6 infection showing localization of PyUIS4 (red)
within PVM and the associated tubulovesicular network (asterisk) characteristic of intracellular developing parasites versus the speckled UIS4
localization within the sporozoites (white arrow). In the quantification of (A), only parasites with UIS4 PVM staining were counted positive for UIS4.
Anti-CSP antibody (green) was used to visualize al parasites (intracellular and extracellular). The nucleus was stained with DAPI (blue). (C) Schematic of
PyROM4TMGFP construct displaying the truncated sequence of PyROM4 used to clone into a vector containing an IgK leader sequence, an N-terminal
GFP tag (green hexagon), and a C-terminal 2xMyc tag (gray triangle). Dashed blue parallel lines represent the boundaries of the TMD (amino acid
sequence in red font color) as predicted by HMMTOP and TMHMM analysis tools (Expasy.org). Arrow depicts the predicted rhomboid cleavage site
between an Alanine and a Glycine. Predicted full length size for PyROM4TMGFP is 40 kDa, and the predicted size for the N-terminal rhomboid cleaved
product is a 34 kDa. (D and E) Western blot analysis of transiently transfected COS7 cells used to detect proteolytic activity of rhomboid against
PyUIS4TMGFP. (D) Western blot of cell lysates probed with anti-HA antibody (Cell a-HA) show proper expression of DmRho-1 (Dm), TgROM5 (TgR5),
and TgROM5
SA (TgR5
SA) in the first three lanes and no detection of protein in the ‘‘no rhomboid’’ (–) negative control in the fourth lane. (E) Processing
of PyUIS4TMGFP (anti-GFP_UIS4) was analyzed by western blot of cell lysates (upper panel, Cell) and concentrated media fraction (lower panel,
Media) by probing with anti-GFP antibody. Full length PyUIS4GFP is observed in the cell fraction at the expect size of ,40 kDa. A lower molecular
weight product (,34 kDa) is detected in both cell and media fractions (arrow) only in the first lane where DmRho-1 (Dm) is co-expressed. No cleaved
product is seen when PyUIS4TMGFP is co-expressed with TgROM5 (TgR5), TgROM5
SA (TgR5
SA), and the ‘‘no rhomboid’’ negative control (–).
doi:10.1371/journal.ppat.1002197.g007
Plasmodium Protease ROM1 and Vacuolar Development
PLoS Pathogens | www.plospathogens.org 11 September 2011 | Volume 7 | Issue 9 | e1002197during intracellular development within the mammalian host
suggests that ROM1 function is linked to proper PV formation
and maturation either during or post invasion.
Ultrastructural analysis at four hours post invasion reveals that
pyrom1(-) parasites are capable of forming a PVM during hepatic
development. But, the PVM in the pyrom1(-) parasites is intimately
associated to the plasma membrane of the mutant parasite. In
comparison, after invasion, wildtype parasites have substantially
expanded their PV space, which is visible as a white ‘halo’
surrounding the intracellular parasite. When parasites first enter
host cells, they have a tight fitting vacuole. Shortly after invasion,
the vacuolar space expands, representing a modification of the PV.
This modification is accompanied by targeting of parasite proteins
to the PVM as well as changes in the lipid composition of the
specialized vacuolar membrane [12].
Notably, a fraction of pyrom1(-) parasites had a PV space similar
to the wildtype parasites. We hypothesize that these are the
parasites go on to develop normally into liver schizonts. These
parasites may be able to progress due to a redundant function of
other proteases such as ROM4 or ROM8, which are also
expressed in sporozoites [44,66]. Thus, pyrom1 (-) parasites display
a partial penetrance phenotype where only a fraction (50–70%) of
Figure 8. Ultrastructural analysis of pyrom1(-) parasites reveals an abnormal parasitophorous vacuole. (A) Representative electron
micrograph images of intracellular parasites developing within a Hepa 1–6 host cell at 4 hours post invasion. Inset shows a close up of the boundary
between the parasite and the host cell cytoplasm. Notice the expanded PV space appearing like a halo (*) in the wildtype parasite and a tight fitting
PVM with reduced PV space in the R1KO parasite. Scale bars are equal to 0.5 mm. Abbreviations: SPZ-sporozoite, hC- Host cell cytoplasm, hN- Host cell
nucleus, PVM- Parasitophorous vacuole membrane, PV-Parasitophorous vacuole space, PPM- Parasite Plasma Membrane, IMC- Inner Membrane
Complex. (B)) Quantification of PV space area (halo area) and parasite area was carried out using ImageJ software. The ratio of halo area/parasite area
6 SEM for Wildtype parasites (Wt Ctrl) was 0.16860.017 (N=38) and for R1KO parasites was 0.09460.013 (N=44). Statistics was carried out using
One-way ANOVA analysis. (C) The graph shows the distribution of the parasite population as a function of the ratio halo area/parasite area between
wildtype (Wt Ctrl) and pyrom1(-) (R1KO). A shift in the R1KO population towards a smaller ratio (.0.00 to 0.05) is observed and is denoted by an
asterisk (*).
doi:10.1371/journal.ppat.1002197.g008
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remainder fraction go on to develop normally. In addition to
redundant function and partial complementation by another
protease, this partial penetrance phenotype is explained by a
stochastic mechanism where levels of processed substrate(s) must
reach a threshold level to allow normal parasite development [74–
76]. In systems biology, such a stochastic mechanism occurs when
a gene encodes for a non-essential phenotypic capacitor that serves
to buffer various development, environmental, and genetic
stresses. Since PyROM1 encodes an enzyme, it is subject to
random biomolecular interactions that promote phenotypic
variation.
A previous study showed that intracellular parasites, deficient in
two sporozoite specific proteins, p52 (p36p) and p36, were
negative for UIS4 staining at the PVM [63]. Like pyrom1(-)
parasites, mutant parasites in p36/p52 have normal gliding,
traversal, and hepatocyte invasion. However, unlike pyrom1(-)
parasites, which are capable of establishing a PVM, p52 mutant
and p36/p52 double mutant parasites failed to develop inside the
hepatocyte due to an inability to establish or maintain a PVM
during early infection [26,63,77–79]. Interestingly, pyrom1(-)
parasites have a 30% decrease in UIS4 staining at 2 hours and
6 hours post invasion, despite their ability to invade cells normally.
If the PVM is established in conjunction with invasion, then the
absence of UIS4 in the pyrom1(-) parasite vacuoles reflects a defect
in the targeting of UIS4 to the PVM shortly after invasion and not
necessarily a defect in establishing a PV.
The mechanisms by which UIS4 or other eTRAMPS are
secreted and associate to the PVM are still unknown. A previously
published analysis suggested eTRAMP proteins have a TMD with
sequence similarity to the canonical rhomboid substrate, Spitz
[32]. Here, we show for the first time that the transmembrane
domain of an eTRAMP, PyUIS4, serves as a rhomboid substrate
to DmRho-1. Unfortunately, we were not able to express a
catalytically active pyROM1 (data not shown) to test activity
against candidate substrates, including known substrates of the
PyROM1 homolog, PfROM1 such as AMA1 or Spitz [39].
Therefore, we could not determine directly whether PyROM1
cleaves UIS4.
Little is known about the dynamic processes that occur just after
invasion when the parasite has entered a new environment and
must undergo dramatic changes. It is well established that cells
sense changes in their environment from external cues that
activate a signaling cascade through an internal sensor such as a
surface receptor. A function in the activation of a signaling
molecule has been described for rhomboid proteases in several
species [80]. A recent study has attributed such a function to
rhomboid protease activity in the parasite Toxoplasma gondii [81]. In
this study, TgROM4 dominant negative mutants defective in
replication were rescued by the over-expression of the cytoplasmic
tail of TgAMA1 or PfAMA1 that resembled the rhomboid
cleavage product [81]. Based on these results, intramembrane
proteolysis of AMA1 is hypothesized to link the switch from
invasion to replication. A biological role for rhomboid processing
of AMA1 in Plasmodium spp has not been established since it is a
minor event that is enhanced when the subtilisin protease PfSUB2,
is inhibited [30,38,82]. Given that PfROM1 preferentially cleaved
PfAMA1 relative to the TgROM4 ortholog, PfROM4 [39] and
our current data, it is possible that ROM1 plays a role in a similar
process in Plasmodium species.
A separate study, using conditional knockdowns, showed
TgROM4 functions as a sheddase of surface adhesins during
gliding motility and invasion [83]. Our studies demonstrate that
ROM1 does not directly function as a sheddase during cell entry,
but instead is important in the stages just after invasion of
hepatocytes. Therefore, as proposed for TgROM4 [81], we
hypothesize that ROM1 activity links parasite invasion of host cells
with parasite development within host cells. In a second model,
ROM1 may function as a secretase that promotes the secretion of
proteins such as UIS4 that are targeted to the PV or PVM for
modification. A secretase activity may also serve to activate the
secretion of a signal for parasite differentiation. In both models,
ROM1 processing activity could occur prior to or after invasion.
Further studies to identify substrates of ROM1 are needed to
understand ROM1 function. Most importantly, this study provides
new insights into the function of a rhomboid protease during
intracellular development of Apicomplexan parasites.
Materials and Methods
Infection of mice, the parasite life cycle, mosquitoes, and
cell lines
For routine passage of blood stage Plasmodium yoelii 17XNL
parasites and for mosquito feedings, Swiss Webster mice (female,
4–5 weeks) were used. Mice were infected by either intraperitoneal
or intravenous injections. For parasite infectivity assays such as
liver parasite burden or blood stage infectivity, BALB/c mice
(female, 6 weeks of age) were used. Blood stage parasites were
harvested by intraocular bleeding of infected mice. All animals
were purchased from either Charles River or Taconic.
Handling of mice and rodent malaria infections were conducted
in accordance to approved protocols by the institutional animal
use committees at Albert Einstein College of Medicine (protocol
20081001) and New York University School of Medicine (protocol
090809-02), in facilities approved by the Association for Assess-
ment and Accreditation of Laboratory Animals. Protocols followed
the recommendations of the Guide for the Care and Use of
Laboratory Animals of National Institutes of Health Office of
Laboratory Animal Welfare.
Anopheles stephensi mosquitoes were reared at 27uC and 80%
humidity under a 12/12 h light/dark cycle, and adults were fed on
20% sucrose solution. Three to five- day old mosquitoes were used
for feeding on infected mice with P. yoelii 17XNL and maintained
at 24uC, 80% humidity.
All cells used were grown in Dulbecco’s modified Eagle’s
medium supplemented with 10% heat inactivated fetal bovine
serum, 1 mM Glutamine, 100 U Penicillin/ml, 10 mg/ml strep-
tomycin, and maintained at 37uC and 5% CO2.
Cloning of pyrom1
The gene encoding pyrom1 was cloned by RT-PCR using total
RNA from Plasmodium yoelii 17XNL mixed blood stage parasites
extracted with TRIzol reagent (Invitrogen) followed by DNAse
treatment (Ambion). Full length sequence of the pyrom1 cDNA was
amplified via 59 and 39 Rapid Amplification of cDNA Ends
(SMARTRACE, Ambion BD Biosciences) using primers pyR1RA-
CE59R and pyR1RACE39F. A touchdown PCR was carried out to
increase the specificity of the PCR reaction. The PCR reaction
productswereseparatedbyagarosegelandPCR products of various
sizes were gel extracted (Qiagen) and cloned to a Topo vector
(Invitrogen) for sequencing. Gene sequence of the open reading
frame was further confirmed via RT-PCR using primers, pyR1.1-F
and pyR1.1-R, specific to the deduced 59 and 39 ends of the pyrom1
open reading frame. Exon/intron boundaries were confirmed to
follow the conserved splicing motifs. Functional prediction of the
translated amino acid sequence was obtained by using the Translate
tool on the Expasy website (www.expasy.org). Prediction of
transmembrane domains was performed using the TMHMM
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HMMTOP (http://www.enzim.hu/hmmtop/). Primer sequences
are listed in Table S3.
RNA extraction and expression analysis by real-time qRT-
PCR
Total RNA was prepared from synchronized Plasmodium yoelii
parasites at various time points during development. Erythrocytic
stages were synchronized by injecting 1610
8 purified schizonts into
5 wk old Swiss Webster mice (Charles River) by tail intravenous
injection [84]. Specific synchronized erythrocytic stages were
confirmed by Giemsa stained blood smears and collected at
specified time points to obtain a ring stage, trophozoite stage, and
schizont stage parasites. Mice infected with synchronized parasites
were fully bled into heparinized complete medium. Infected blood
was saponin lysed, centrifuged at 4uC, and the resulting parasite
pellet was resuspended in 500 ml of TRIzol reagent (Invitrogen). To
collect RNA from mosquito stage sporozoites, midguts or salivary
glands were dissected from 100 infected (P. yoelii 17XNL) A. stephensi
mosquitoes at 10 days post blood meal (midgut sporozoites) or 14
days post blood meal (salivary gland sporozoites). Midguts or
salivary glands were dounce-homogenized in 500 ml of TRIzol
reagent. For all of the TRIzol samples, RNA was extracted followed
by treatment with DNAseI (Ambion), and passed through an
RNeasy Cleanup column (Qiagen). Total RNA (1 mg) was
incubated with random hexamers and used to make cDNA using
the Superscript III First-Strand Synthesis System (Invitrogen)
according to manufacturer instructions. Real-time PCR was carried
out ina 10 ml volume usingSYBR Green PCRmasterMix(Applied
Biosystems) and 1 mM gene specific primers. Real-time PCR was
performed using the ABI Prism 7300 qPCR machine (Applied
Biosystems). Transcript expression of pyrom1 was normalized to the
expression of the control gene, 18s rRNA. The normalized
expression for each gene was determined by the ddCt method
[85] and values are expressed relative to the expression of the
schizont stage. Primers used for real time PCR were designed using
Primer Express Software (Table S3).
Targeting vector construction and parasite transfection
P. yoelii 17XNL genomic DNA was used to amplify two 600 base
pair (bp) fragments that are upstream and downstream of the
pyrom1 coding region using primers, pyR1.59KpnI-F, pyR1.59X-
hoI-R, pyR1.39BamHI-F, pyR1.39NotI-R, containing appropriate
restriction sites to facilitate cloning of the PCR fragments into the
PMD205GFP vector [48]. This vector contains a selection cassette
that expresses the P. berghei dihydrofolate reductase-thymidylate
synthase (pbDHFR-TS) gene fused to the Green Fluorescent
Protein (GFP) open reading frame under the control of the
pbDHFR promoter. The resulting targeting construct contains the
pbDHFR-TS/GFP selection cassette flanked by the upstream
(59ARM) and downstream (39ARM) fragments from the pyrom1
genetic locus. The targeting vector was linearized using restriction
enzymes KpnI, NotI, and ScaI prior to transfection. For the
transfection, a total of 15 mg of linearized vector DNA was mixed
with 5610
7 schizonts resuspended in 100 ul of cytomix [86] and
transferred to an AMAXA cuvette for electroporation using the
AMAXA nucleofector [87]. Pyrimethamine (1 mg/kg) treatment
in the drinking water was started 24 hours post transfection and
maintained until the appearance of drug resistant parasites.
Southern blot analysis
Mixed blood stage parasites were released from host erythro-
cytes by treatment with 0.05% Saponin in ice-cold PBS. Parasite
pellet was incubated with 2 mg/ml Proteinase K (Roche) at 37 C
for 2 hours and genomic DNA (gDNA) was extracted using
phenol/chloroform, chloroform extraction, followed by ethanol
precipitation. Genomic DNA (2 mg) was treated with the
restriction enzymes (New England Biolabs) overnight for complete
digestion. To test for successful gene replacement in R1KO,
gDNA was digested with enzymes ScaI/MscI or ScaI alone. To
analyze integration of the N-terminal HA tag in R1HA parasite
line, gDNA was digested with enzymes BstZ171 and MscI.
Restricted DNA was separated by gel electrophoresis on a 0.8%
agarose gel, transferred via capillary action to a Nylon membrane
(Roche). DNA probe specific to the 39homologous region was
amplified using PCR and Digoxigenin (DIG) labeled nucleotides
(Roche). Probe hybridization and chemiluminescent detection
were carried out using manufacturer’s instructions (Roche).
N-terminal tagging of pyrom1 with a triple HA epitope
The spliced open reading frame amplified from P. yoelii 17XNL
cDNA was cloned into a vector containing an N-terminal triple
HA tag using the EcoRI and NotI restriction sites [33]. The 59
flanking region (FR) was amplified from gDNA (1.5 kb) and was
cloned into a pBluescript SK(-) (Stratagene) plasmid using
restriction sites ApaI and XbaI to generate pB59FR. The HA-
pyrom1 fragment was subsequently cloned within the XbaI and
Not I sites to generate the pB59FRHAR1 plasmid. The 39FR
(1 kb) was then cloned using NotI and SacII sites into the
pB59HAR1 plasmid to generate pB59FRHAR139FR plasmid. The
entire insert containing a 59FR, an N terminally tagged pyrom1
ORF, and a 39FR, was then cut out with ApaI and SacII and was
cloned into the PL0006 vector that contains the hDHFR selectable
marker (Leiden) to ultimately generate the pR1HA knock-in
vector. Prior to P. yoelii transfection the pR1HA vector was
linearized with the restriction enzyme Aria in order to promote
homologous recombination within the 59FR. Transfection was
carried out as described above. Following pyrimethamine
treatment (1 mg/kg), recombinant parasites were analyzed by
PCR and Southern blot analysis of gDNA. Expression of tagged
ROM1 was verified by Western Blot. Immunofluorescence
microscopy was then carried out to analyze expression and
localization of pyROM1 during different stages of the parasite life
cycle. Primer sequences are listed in Table S3.
Immunofluorescence microscopy of pyROM1-HA
Thin smears of mixed blood stages were fixed in ice cold
acetone/methanol (1:1) for 3 minutes, blocked with 3% BSA/
PBS, incubated with appropriate primary antibody, followed by
secondary antibody. Washes were carried out using PBS-Tween
20 (0.005%). Salivary gland sporozoites were centrifuged onto 8-
well glass Labtek chambers (Nunc), fixed with 4% Paraformalde-
hyde, and permeabilized with 0.2% TritonX-100. Fixed sporozo-
ites were then blocked and incubated with antibody as described
above. Washes were carried out using 16 PBS. For IFA of liver
stages, infected Hepa1–6 cells at specified time points were fixed
with ice cold methanol for 15 minutes and incubated with
antibodies as described below. To capture invading R1HA
sporozoites, Hepa1–6 cells were infected for 10 minutes, fixed
with 4% paraformaldehyde, blocked, and stained with a-pyCSP to
detect extracellular or invading parasites, permeabilized with ice
cold 100% methanol, and incubated with rabbit a-HA to detect
pyROM1-HA. Primary antibodies used were 1/1000 rabbit a-HA
(Sigma), 1/100 a-pyCSP 2F6 from hybridoma supernatants, 1/
500 a-HA rat mAb 3F10 (Roche), 1/1000 rabbit a-pyMAEBL
YM2T8 antisera [88–89], 10 ug/ml rabbit a-PfBiP antisera (MR4
ATCC, MRA-20), 1/500 and rabbit aUIS4 antisera [15].
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(Molecular Probes) were used and 0.02 mg/ml of 496-diamidino-2-
phenylindole (DAPI) was used for nuclear staining. Images were
taken at 1006 magnification with the Upright Olympus BX61
microscope using the IP Lab 4.0.8 software through the Analytical
Imaging Facility of the Albert Einstein College of Medicine.
Phenotypic analysis of intra-erythrocytic parasite
infectivity in mice
An inoculum of 1610
4 mixed blood stage parasites from R1KO
and wildtype parasites was injected intravenously into five 6-week
old female BALB/c mice (Charles River). Parasitemia was
monitored by daily blood smears from each infected mouse,
stained with Giemsa (Sigma) and counted under light microscopy.
Percent parasitemia was determined by counting at least 1,000 red
blood cells per smear and calculated as the percentage of infected
red blood cells (iRBC) to total number of red blood cells.
Phenotypic analysis of parasite development in
mosquitoes
Swiss Webster mice (4 weeks, female) were injected intrave-
nously with 5610
7 infected RBC from either wildtype or R1KO
parasites. Two days later, starved Anopheles stephensi mosquitoes
were fed on the infected mice harboring mature gametocytes for
15 minutes. A second 5 minute feeding was carried out the
following day. Parasite transmission and infectivity was deter-
mined by counting the number of oocysts from dissected midguts
at day 8 post feeding and the number of salivary gland associated
sporozoites at day 14 post feeding under a light microscope.
Gliding motility assay
At day 14 post blood meal feeding, mosquito salivary glands
were dissected and sporozoites were collected and counted using a
hemocytometer. Salivary gland sporozoites (3610
4) were added to
8-well Lab-Tek glass slides (Nalgene) that had been pre-coated
with 200 ml of 10 ug/ml a-pyCSP (mAb 2F6) antibody in PBS at
room temperature, overnight. Loaded Lab-Tek slides were
incubated for 1 hr at 37uC to allow sporozoite gliding, after a
brief centrifugation (500 RPM, 1 minute). Media was removed
and wells were immediately fixed with 4% Paraformaldehyde at
4uC overnight. Wells were blocked with 1% BSA/PBS solution,
incubated with biotinylated mAb 2F6 (1 hour, 37uC, 1/100
dilution), and stained with streptavidin-Alexa 488 (Molecular
Probes). Trails were visualized and counted under a fluorescence
microscope.
Cell traversal assay
Salivary gland sporozoites (3610
4) were dissected in 1% BSA/
DMEM and loaded onto Hepa 1–6 cell monolayers in the presence
of 1 mg/ml FITC-dextran (10,000 MW; Molecular Probes). In
control wells, sporozoites were pre-treated for 10 minutes with
1 mM of Cytochalasin D on ice before being loaded onto cells.
Sporozoiteswerecentrifuged(1000RPM,3 minutes)and incubated
for 1 hour at 37uC. Cells were washed extensively with 16PBS to
remove excess FITC-dextran that had not been taken up and were
fixed with 4% Paraformaldehyde, mounted and visualized under a
fluorescent microscope at 406 magnification. The number of
FITC-positive cells was counted in at least 30 fields and values
represented are FITC-positive cells per field.
Sporozoite invasion and development assays
For invasion assay, semi-confluent Hepa 1–6 cells were loaded
with 5610
4 P. yoelii WT or R1KO salivary gland sporozoites and
centrifuged (1000RPM, 3 minutes). After 2 hour or 6 hour
incubation at 37uC to allow invasion, media was removed and
cells were washed with PBS, fixed with 4% paraformaldehyde for
30 minutes, and blocked for 1 hour at 37uC with 1% BSA/PBS.
Cells were incubated with the a-pyCSP 2F6 mAb following the
Red-Green double staining method to distinguish intracellular
versus extracellular parasites [60–61]. For liver development
assays, Hepa 1–6 cells were loaded with 5610
4 P. yoelii Wt or
R1KO salivary gland sporozoites, spun down and incubated for 6,
12, and 24 hours to allow EEF development. At the end of each
time point, cells were fixed with ice-cold methanol and stained
with either mAb 2F6 (a-pyCSP) or mAb 2E6 (a-HSP70) [90] to
visualize and quantify parasite development. At least 50 fields were
counted per well and each experiment was done in duplicate or
triplicate. For detection of UIS4 positive PVM salivary gland
sporozoites were incubated for 2 or 6 hours with Hepa 1–6 cells as
describe above. After each time point, cells were fixed with 4%
paraformaldehyde for 30 minutes at room temperature followed
by permeabilization with 100% ice cold methanol for 10 minutes.
Double staining was performed using a-PyCSP 2F6 mouse
monoclonal antibody and a-PyUIS4 rabbit polyclonal antibody
for 1 hour at 37uC. Staining with secondary antibodies was
followed with goat a-mouse IgG–Alexa 488 and goat a-rabbit
IgG-Alexa 568. The percent of parasites double staining (CSP-
UIS4) over total number of parasites (CSP only) was recorded in
duplicate. Statistical analysis was carried out using either One-way
ANOVA multiple comparison test or unpaired t-test with the
GraphPad Prism software.
Quantitative analysis of liver infectivity in vivo
Analysis of malaria infection in mouse livers was carried out as
described previously [50]. Salivary gland sporozoites from wild-
type or R1KO infected mosquitoes were collected and counted
using a hemocytometer. Female BALB/c mice 6 weeks of age
(purchased from Charles River) were intravenously injected with
1000 or 10,000 sporozoites. Four or five mice were independently
injected per parasite line. Livers were harvested 36 hours later and
homogenized in 10 ml of TRIzol reagent (Invitrogen). RNA was
extracted from 1.5 ml of liver homogenate, treated with DNAseI
(Ambion) and purified with an RNeasy purification column
(Qiagen). Total RNA (4 mg) was used to make cDNA using the
Superscript III cDNA synthesis system (Invitrogen) and random
hexamers as primers. Quantitative PCR was carried out with the
ABI 7300 apparatus using the POWER SYBR green master mix
(Applied Biosystems) in a 20 ml reaction volume containing 2 mlo f
cDNA and 1 mM of primers. Test Primers to detect parasite
burden within liver were to the Plasmodium 18s rRNA gene and the
internal control primers were specific to the mouse GAPDH gene.
Relative transcript quantification was determined using the 2
2ddCt
method.
Heterologous cleavage assay in COS7 cells
HA-tagged rhomboid expressing plasmids (DmRho-1,
TgROM5, TgROM5
SA) were obtained from Dr. Sinisa Urban
as published in [33]. A truncated PyUIS4 that excludes the
predicted signal sequence and most of the C-terminal domain was
amplified from sporozoite cDNA. The reverse primer was
designed to include a 2xMyc tag. This PCR product was fused
to GFP preceded by an IgK leader sequence via PCR joining
using primers listed in Table S3. The resulting PCR was inserted
into the pcDNA3.3 TOPO TA cloning vector. The template for
GFP is from the Spitz-GFP expression plasmid used in [33]. The
cleavage assay was carried out as described in [33,39] with minor
modifications. Briefly, COS7 were seeded on 6-well plates and
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Fugene6 (Roche) reagent following manufacturer’s protocol. For
PyUIS4TMGFP, 250 ng of plasmid DNA was used per well and
100 ng of plasmid DNA was used for rhomboid constructs. A
pBluescript (Stratagene) plasmid was used as filler DNA. At
18 hours post-transfection, media was removed, cells were washed
with serum-free media (SFM), and 800 ml of SFM containing
protease inhibitor Galardin (GM_600, Biomol) was added. The
conditioned media was collected and cells were harvested by lysis
with sample buffer at 18–24 hours later. Media fraction was
concentrated using Centricon (Millipore) centrifugal concentrator
with a cut off of 3 kDa. Western blot analysis was carried out for
both media fractions and cell lysates. Anti-GFP antibody (Santa
Cruz Biologicals) was used to detect PyUIS4TMGFP and anti-HA
mAb clone 3F10 (Roche) was used to detect rhomboid constructs.
Electron microscopy of early hepatic stages
Salivary gland sporozoites (1610
6) were dissected and loaded
onto a confluent monolayer of Hepa1–6 cells at an MOI of 2:1
(5610
5), centrifuged (1000 RPM, 3 minutes), and allowed to
invade for two hours. Infected cells were washed with media
containing 106 Pen/Strep and 0.25 mg/ml of Fungizone
(Invitrogen) to remove debris and unbound sporozoites.
Development was allowed to continue another two hours for a
total of four hours of development. Cells were then washed with
PBS, trypsinized, and washed one more time with PBS, followed
by fixation with 2% Paraformaldehyde/2.5% Glutaraldehyde
for 1 hour at room temperature. Cells were washed with PBS
and postfixed in 1% osmium tetroxide (Polysciences Inc.,
Warrington, PA) for 1 hour. Samples were then rinsed
extensively in dH20 prior to en bloc staining with 1% aqueous
uranyl acetate (Ted Pella Inc., Redding, CA) for 1 hour.
Following several rinses in dH20, samples were dehydrated in a
graded series of ethanol and embedded in Eponate 12 resin (Ted
Pella Inc.). Sections of 95 nm were cut with a Leica Ultracut
UCT ultramicrotome (Leica Microsystems Inc., Bannockburn,
IL), stained with uranyl acetate and lead citrate, and viewed on
a JEOL 1200 EX transmission electron microscope (JEOL USA
Inc., Peabody, MA). Image J software was used for quantifica-
tion of the PVM/PV area in the EM images and statistical
analysis was carried out with the GraphPad Prism software
using unpaired t test. Measurements were made by on blinded
images.
Supporting Information
Figure S1 Schematic representation of pyROM1 gene
structure and sequence. Sequence of pyROM1 was obtained
from blood stage cDNA using 59RACE and 39RACE. A) The gene
comprises two predicted open reading frames on PlasmoDB
(py00728 and py00729). Pyrom1 is composed of four exons
(including UTRs) and three introns. Exons (labeled with roman
numerals I–IV) are represented by the gray boxes and the introns
by the thin gray lines. Numbers below each exon represents the
nucleotide length of the coding region of the exon. The codons for
the catalytic Serine (S) and Histidine (H) residues are encoded
within exon III. B) Nucleotide sequence of the Open Reading
Frame (ORF) of pyrom1 with the corresponding translated amino
acid sequence. Nucleotide or amino acid position is marked by the
numbers on the left margin. The microneme targeting motif
within the N-terminal tail of pyROM1 is boxed. The transmem-
brane domains are shaded in gray. The catalytic Serine (S) and
Histidine (H) are in red color.
(TIF)
Figure S2 Gene expression controls for qRT-PCR in
various stages of the Plasmodium yoelii life cycle.
Quantitative RT-PCR (qRT-PCR) was carried out using the
method described in this work using the same cDNA used to
obtain results in Figure 1A. Primers for qRT-PCR were designed
to amplify PyADA, PyAMA, PyTUB1, PyUIS3, and PyCSP.
Transcript expression was normalized to the expression levels of
the ribosomal rRNA 18s. The calibrator used to plot relative
expression varies, and is denoted as a subscript in the title of the
legend on the Y-axis. (A) Expression analysis of three gene
expressed during erythrocytic blood stages. PyADA encodes the
enzyme Adenosine Deaminase involved in purine salvage
metabolism. PyTUB1 encodes for alpha tubulin1, a structural
protein prominent in the zoite stages. PyAMA (PlasmoDB:
Py01581) is a gene whose product is a microneme invasion
adhesin involved in host cell invasion expressed in erythrocytic and
sporozoite stages. (B) Expression analysis of three genes expressed
during mosquito and pre-erythrocytic stages. PyCSP (PlasmoDB:
Py03168) encodes for Circumsporoozite protein expressed during
oocyst development, salivary gland sporozoite, and early pre-
erythrocytic stages. PyUIS3 (PlasmoDB: Py03011) encodes for
Upregulated in Sporozoite 3, a member of the eTRAMP family
specifically upregulated in salivary gland sporozoites with
continued expression during pre-erythrocytic stages.
(TIF)
Figure S3 Genetic disruption of the pyrom1 gene. A)
Schematic of strategy for disrupting the pyrom1 locus using
integration plasmid R1INT. A 600 bp fragment representing the
middle portion of the pyrom1 ORF excluding the 59 and 39 ends
was amplified from gDNA by PCR. This fragment was cloned
onto the PMD205GFP vector [48] using BamHI and NotI
restriction sites to generate R1INTPMD205GFP targeting vector.
The plasmid was linearized using restriction enzyme BsiWI to
facilitate homologous recombination. B) For Southern blot
analysis, 3 mg of genomic DNA was digested with restriction
enzyme PacI (New England Biolabs). Digested DNA was
separated on a 0.8% agarose gel and transferred to a nylon
membrane (Roche Applied Science). A probe (orange line)
encompassing the region used for homologous recombination for
the pyrom1 gene was amplified by PCR using digoxigenin (DIG)-
labeled UTP nucleotides (Roche Applied Science). Southern blot
was revealed using an anti-DIG antibody coupled to peroxidase
(Roche Applied Science). A unique specific band at 1858 bp (black
arrowhead) for the wildtype gDNA is seen in one of the transfected
clones (lane 2) and two bands at 7565 bp and 2343 bp (pink
arrowheads) representing successful disruption of pyrom1 are seen
in two clones (lanes 1 and 3). As a control, the PacI linearized
episome (Epi) runs at the expected size of ,8775 bp (black arrow).
C) Verification of successful pyrom1 disruption at the RNA level.
Two different primer sets (pyrom1.1 and pyrom1.2) were used to
amplify the pyrom1 gene from cDNA of wildtype parasites and
disrupted parasites clone 1 (lane 1 from southern blot in B).
Amplification of ADA, an unrelated gene, was used as an internal
control. No Reverse Transcriptase (RT) cDNA samples were used
as a control for gDNA contamination.
(TIF)
Figure S4 Representative electron microscopy images
of pyrom1(-) parasites displaying the parasitophorous
vacuole phenotype. Intracellular parasites at 4 hour develop-
ment within Hepa 1–6 host cells. Notice the well defined white
‘halo’ surrounding the parasite within the PV observed in the
wildtype parasites (A,C,D,F) in contrast to phenotype displayed by
R1KO developing parasites (B,D,F,G). Inset shows a close up of
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Scale bars are equal to 0.5 mm. Abbreviations: PVM- Parasito-
phorous vacuole membrane, PV-Parasitophorous vacuole.
(TIF)
Table S1 In vivo transmission and pre-patent period of
pyrom1 (-) parasites. Balb/c mice (Female 6 weeks, N=5)
were infected by either natural mosquito bite (10 mosquitoes/
mouse for 5 mins) or by intravenous injection of salivary gland
sporozoites (20, 200, 2000). Peripheral blood parasitemia was
monitored by Giemsa stained blood smears starting at day 3. Pre-
patent period represents the number of days from initial infection
until the appearance of blood parasites.
(DOC)
Table S2 Quantitative analysis of the parasitophorous
vacuole space in pyrom1(-) parasites. Electron microscopy
images of intracellular parasites at four hours development within
hepatocytes were used to quantify the area of the PV space and
qualitatively describe the parasitophorous vacuole. Observers were
blinded as to image identity. Statistical analysis was performed
with GraphPad Prism software using unpaired t test (p
value=0.0005).
(DOC)
Table S3 Primer sequences used in study. List of primers
used throughout the study as referred to in the materials and
methods. Sequences underlined correspond to restriction enzyme
sites used to facilitate cloning. Bold letters within primer nucleic
acid sequence correspond to the sequence of PyUIS4 sequence
used to amplify the transmembrane domain (PlasmoDB accession
number py00204).
(DOC)
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